Emergent BioSolutions Inc. (EBS) Stock Overview
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other…
Source: Yahoo Finance
Sector & Industry
Emergent BioSolutions Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NYSE exchange.
Emergent BioSolutions Inc. at a Glance
| Company | Emergent BioSolutions Inc. |
| Ticker | EBS |
| Exchange | NYSE |
| Currency | USD |
| Price | $6.21 |
| Market cap | $318.41M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.41 |
| 52-week high | $14.06 |
| 52-week low | $4.36 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.34 |
| Return on equity (ROE) | -40.29% |
| Debt-to-equity | 172.29% |
| Average volume | 1.08M |
| Shares outstanding | 51.27M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 900 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Emergent BioSolutions Inc.'s current P/E ratio?
- Emergent BioSolutions Inc. (EBS) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Emergent BioSolutions Inc.'s market capitalisation?
- Emergent BioSolutions Inc.'s market cap is $318.41M based on our latest snapshot. See how it ranks by market cap →
- What is EBS's 52-week range?
- Over the past 52 weeks, EBS has traded between $4.36 and $14.06. What does the 52-week range mean? →
- How volatile is Emergent BioSolutions Inc. compared to the market?
- Emergent BioSolutions Inc. has a beta of 2.34, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Emergent BioSolutions Inc. pay a dividend?
- Emergent BioSolutions Inc. does not currently pay a dividend according to our latest data.
- What exchange is EBS listed on?
- EBS is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Emergent BioSolutions Inc. in?
- Emergent BioSolutions Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →